Objectives To review the competence of Omega-3 fatty acids in restricting the progression, thereby leading to prevention of diabetic retinopathy. Key findings Owing to their anti-inflammatory and anti-angiogenic properties, Omega-3 fatty acids alleviate major aetiological agents. These fatty acids are renowned for their beneficial effects in various cardiovascular and other disorders; however, their potential to prevent the progression of diabetic retinopathy remains least explored. Summary Utilizing this potential, we may develop effective prophylactic agents which markedly inhibit the advent of retinal angiogenesis and prevent the apoptosis of retinal endothelial and neuronal cells, thereby averting retinal degeneration, hence safeguarding diabetic patients from this sight-threatening complication.
Introduction
Diabetic retinopathy, a neuro-microvascular complication associated with diabetes mellitus, is a sight-threatening condition in which hyperglycaemia-induced various pathological alterations (such as oxidative stress, inflammation, angiogenesis, accumulation of advance glycation end products, overactivation of protein kinase C (PKC), increased apoptosis of endothelial cells and neurons) target and damage the retinal blood capillaries. The combined damage induced by all the mentioned noxious stimuli leads to endothelial dysfunction, hence increasing its permeability, and ultimately resulting in macular oedema. [1] Moreover, the inflammatory response worsens the situation and stimulates several angiogenic factors leading to retinal neovascularization. Besides, oxidative stress (prevalent during hyperglycaemia) causes immense damage to both retinal endothelial cells and neurons, accounting for retinal degeneration. The cumulative effect of all the above-mentioned pathological events induces an enormous stress on retina and posterior wall of vitreous chamber, leading to retinal detachment, the ultimate event responsible for vision-loss associated with this complication. [2] [3] [4] [5] [6] Henceforth, owing to the severity of its consequences, researchers are greatly concerned for discovering therapeutic and preventive agents, which could inhibit the progression of this complication.
Omega-3 fatty acids are polyunsaturated fatty acids (PUFAs) found in several dietary components such as seeds, beans, nuts and fish oil. Their inclusion, in right proportions, in our daily diet is highly recommended. The beneficial effects of Omega-3 fatty acids in the prevention of various cardiovascular diseases are widely acclaimed since a long time. The molecular mechanisms of the same have been defined in terms of their anti-inflammatory properties. Agonism of GPR120, a receptor for Omega-3 fatty acids, is demonstrated to be involved in eliciting potent anti-inflammatory effects by blocking the signalling of several pro-inflammatory mediators such as transforming growth factor-b-activated kinase 1 (TAK1), mitogenactivated protein kinase kinase 4/Janus kinase (MKK4/ JNK) and inhibitor of nuclear factor-kappa-B kinase subunit beta (IKKb). The same receptor when is activated by agonists also increases insulin sensitivity. [7] Other protective molecular mechanisms of Omega-3 fatty acids against cardiovascular diseases include disruption JNK signalling by decreasing the expression of tumour necrosis factor-alpha (TNF-a). [8] Besides, the metabolic products of Omega-3 fatty acids, namely resolvins, protectins and maresins, are also anti-inflammatory in nature and hence counteract inflammatory responses during cardiovascular diseases. [9] This review gives a detailed account of the molecular targets of each of the three Omega-3 fatty acids (alphalinolenic acid (ALA), eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA)), which can be utilized for delaying/inhibiting the various pathological alterations induced during hyperglycaemia and thereby prevent the progression of its microvascular complications. Focusing on diabetic retinopathy, we describe the different pharmacological actions of ALA, EPA and DHA, which collectively aid in combating the various factors/mediators involved in its pathophysiology. [10, 11] Omega fatty acids Omega fatty acids, a family of monounsaturated and PUFAs, primarily encompasses three subtypes -Omega-3, Omega-6 and Omega-9 fatty acids.
Among these, Omega-3 and Omega-6 are a type of essential PUFAs which cannot be synthesized in human body, whereas Omega-9 subtype comprises non-essential monounsaturated fatty acids.
There are three types of Omega-3 fatty acids: 1 Alpha-linoleic acid (ALA) 2 Eicosapentaenoic acid (EPA) 3 Docosahexaenoic acid (DHA) Omega-6 family: Linolenic acid is a chief member. These fatty acids are required by the body for various physiological functions such as promotion of cell growth and development, maintenance of healthy immune system, regulation of metabolic reactions and various cellular signalling pathways, as well as triggering the production of several endogenous molecules (e.g. eicosanoids and endocannabinoids). The correct proportion of their intake is essential for maintaining a healthy body (Table 1) .
Although same enzymes (desaturases and elongases) are responsible for the metabolism of both Omega-3 and Omega-6 fatty acids, their metabolic products differ widely in their pharmacological actions. ALA metabolizes to EPA and DHA, whereas linoleic acid forms arachidonic acid, upon metabolism. As arachidonic acid is a precursor for the formation of pro-inflammatory mediators prostaglandins, thromboxanes and leukotrienes, linoleic acid is involved in aggravating inflammatory responses in the body. In contrast, Omega-3 fatty acids have been proven to possess anti-inflammatory, antithrombotic, anti-arrhythmic and antiangiogenic properties, owing to which they are being utilized as potential targets for the treatment/prevention of diabetes, stroke, Alzheimer's disease, and various cardiovascular disorders (like atherosclerosis, hypertension and coronary artery disease). Apart from this, Omega-6 fatty acids also exert pro-inflammatory actions by regulating various inflammatory processes and inflammatory gene expression. The pro-inflammatory properties of Omega-6 fatty acids play an important role in causation and progression of inflammatory diseases like atherosclerosis, inflammatory bowel disease and Alzheimer's disease. [12] [13] [14] [15] As inflammation and angiogenesis are critically involved in the pathophysiology of diabetic retinopathy, Omega-3 fatty acids might also prove beneficial in inhibiting the progression of this diabetic complication (Figure 1 ).
Pathophysiology of diabetic retinopathy Inflammation
A pivotal role of inflammation in the pathophysiology of diabetic retinopathy is now established and confirmed. It is the result of a complex interplay between several inflammatory mediators. Nuclear factor-kappa B (NF-jB) is a detrimental inflammatory mediator, which plays pivotal role in the pathological conditions such as hyperglycaemia. Activation of NF-jB leads to increased transcription of its various gene targets, among which the most important ones includes the cytokines. [16, 17] Overstimulated cytokines such as TNF-a and various interleukins are further responsible for the induction of cell adhesion molecules, chemokines and other inflammatory mediators (such as cyclooxygenase ). Besides, adhesion molecules and chemokines can also be, directly, induced via NF-jB-mediation. The most deleterious role of TNF-a is the activation of intracellular adhesion molecule-1 (ICAM-1) and vascular cell adhesion molecule-1 (VCAM-1). Both these mediators are potent cell adhesion molecules, primarily aiming at initiating a cascade of events leading to recruitment of leucocytes, followed by their adhesion to the endothelium. This event causes significant damage to the endothelial cells, leading to injury and subsequent breakdown of blood-retinal barrier (BRB). Upon BRB breakdown, the permeability of endothelium increases manifolds, resulting in macular oedema, a characteristic event in diabetic retinopathy. [18, 19] Another potent cytokine, interleukin-1-beta (IL-1b), activates inducible nitric oxide synthase (NOS), subsequently leading to the synthesis of nitric oxide (NO), which reacts with the superoxide radical (produced as a result of mitochondrial dysfunction during hyperglycaemia), resulting in the production of peroxynitrite, a highly reactive species involved in inducing cellular apoptosis as well as mediating vascular endothelial growth factor (VEGF) angiogenic signalling pathway. [20, 21] TNF-a, along with IL1b, also induces excitotoxicity-mediated apoptosis of retinal neuronal cells. [22] IL-6 also intensifies the inflammatory response and contributes to the progression of diabetic retinopathy. [23] [24] [25] Cyclooxygenase-2 increases the production of eicosanoids, such as prostaglandin E 2 , prostaglandin I 2 and thromboxane A 2 . Downstream signalling of these pro-inflammatory prostaglandins results in the induction of VEGF. [26] VEGF further induces the expression of several other inflammatory mediators. It has been demonstrated by various studies that VEGF stimulation acts as one of the prime precursors for the induction of ICAM-1, VCAM-1 and monocyte chemotactic protein-1 (MCP-1) via NF-jB-mediated pathway. MCP-1 performs a similar function as that of ICAM-1 and VCAM-1 but is specific for the recruitment of monocytes. [27] Although VEGF itself gets activated by downstream signalling of COX-2-mediated inflammatory response; interestingly, it also further induces the expression of COX-2. Hence, COX-2 and VEGF repeatedly induce each other's expressions in a cyclic mediation. [28] Furthermore, another inflammatory mediator, named Creactive protein, is found to be highly overexpressed during hyperglycaemia-induced pathological conditions and is proven to mediate certain low-grade inflammatory events, which result in endothelial dysfunction by damaging the endothelial glycocalyx layer. It also induces the expression of various other pro-inflammatory mediators, primarily cytokines, thereby intensifying the inflammatory response. It also inhibits the activity of endothelial nitric oxide synthase (eNOS), leading to decreased production of NO, hence downregulating NO-mediated vasculo-protective effects such as mediation of anti-apoptotic and pro-survival pathways. [29, 30] Hence, inflammation is one of the crucial precursors for initiation of angiogenesis, besides inducing several other pathological damages to the retinal endothelial as well as neuronal cells.
Oxidative stress
It refers to a condition denoting an imbalance in the production and destruction of free radicals. It is mainly induced during hyperglycaemia due to mitochondrial dysfunction, which occurs as follows. Excess glucose leads to overexpression of major glucose-metabolizing pathways, namely glycolysis and citric acid cycle. Both these pathways result in overproduction of NADH (reduced form of nicotinamide adenine dinucleotide) and FADH 2 (reduced form of flavin adenine dinucleotide), which upon entering electron transport chain lead to an increased production of superoxide radical. [31, 32] Besides, another hyperglycaemia-induced pathological alteration responsible for immense production of reactive oxygen species is the accumulation of advanced glycation end products (AGEs). The easy and excess availability of glucose in diabetic condition contributes widely to formation of AGEs. The production of AGEs results from nonenzymatic reactions between free amino group of proteins and carbonyl group of reducing sugars like glucose and fructose, commonly known as Milliard reaction. It is subdivided into three stages, namely early, intermediate and late stages. In the early stage, unstable Schiff base is formed by reaction between free amino group of amines and reducing sugars, which undergoes further rearrangement to form stable Amadori products. These Amadori products, in the intermediate stage by undergoing dehydration, oxidation and chemical reactions, form highly reactive dicarbonyl compounds like glyoxal, methylglyoxal (MGO) and deoxyglucosones. In the last stage, that is late stage of reaction, AGE formation occurs by dehydration, oxidation and cyclization reactions. Overproduction of AGEs leads to overexpression of their receptor -RAGEs (receptor for AGEs), further resulting in production of more reactive oxygen species. It is, in fact, interesting to recognize the fact that free radicals and RAGEs induce overexpression of each other, in a loop, thereby leading to immense oxidative stress. [33, 34] As retina is a highly lipoidal tissue and receives a rich oxygen supply, it is highly vulnerable to oxidative stress-induced damages. Reactive oxygen species are quite infamous for carrying out lipid peroxidation, leading to damage to cellular membranes. However, apart from this, oxidative stress also damages nuclear DNA material and several vital cellular proteins, resulting in cell death. Hence, the endothelial cells and neurons of retina are highly prone to oxidative stress-induced damage and necrosis. [35] The increased blood glucose levels are responsible for producing a wide variety of alterations including increased flux of the polyol pathway, overactivation of PKC, destruction of macular pigment, apoptosis of retinal endothelial cells and induction of inflammation. Polyol pathway is another glucose-metabolizing pathway; but resulting in the formation of sorbitol, an impermeable intermediate. Increased flux of polyol pathway leads to overproduction of sorbitol. As cellular membranes are impermeable to sorbitol, it gets accumulated intracellularly, leading to cell death due to osmotic reasons. [36] Oxidative stress-induced PKC formation takes place as follows. PKC is physiologically activated by phospholipase C: IP3-DAG pathway. As diacylglycerol (DAG) is one of the intermediate metabolite of glycolysis (formed by dihydroxyacetone phosphate, a product of glycolysis), hyperglycaemia leads to its excessive production, thereby leading to PKC overactivation. Consequently, expressions of various inflammatory mediators, including VEGF, transforming growth factor-beta 1, plasminogen activator inhibitor-1, NF-jB, NADPH oxidase and endothelin-1, get increased. These events lead to induction of a robust inflammatory response, which leads to the progression of diabetic retinopathy. [37] Hence, oxidative stress is one of the most deleterious hyperglycaemia-induced pathological alterations involved in the pathogenesis of diabetic retinopathy.
Angiogenesis
It is defined as a process of formation of new blood vessels on the pre-existing ones. It forms the basis of proliferative diabetic retinopathy and is marked by the sprouting of newly formed blood vessels, which being weak and immature easily become prey to oxidative stress-induced damage. As a result, their vascular contents leak out, causing vitreous haemorrhages and macular oedema. Hence, angiogenesis is a key event mediating the pathogenesis of diabetic retinopathy. [38] Various inflammatory mediators act as precursors for the initiation of angiogenesis; the most crucial mediator being VEGF. Physiologically, VEGF is required for maintaining endothelial permeability. However, during hyperglycaemia-induced pathological conditions (such as ischaemia, overactivated PKC and oxidative stress), the expression of VEGF increases manifolds, hence, leading to overexpression of its downstream responses. [39] These include abnormally increased endothelial permeability, initiation of retinal neovascularization and mediation of an intense inflammatory response. During pathological angiogenesis, various isoforms of VEGF interact with VEGFR (VEGF receptors -VEGFR1 and VEGFR2) and induce their survival and overexpression, resulting in mediation of several overregulated functions such as vessel outgrowth, endothelial cell differentiation, migration and tube formation. [40, 41] In addition, VEGF stimulates other detrimental mediators of angiogenesis, such as matrix metalloproteinases (MMPs). MMPs are extracellular components, responsible for degrading cellular proteins present in both matrix and non-matrix compartments of the body. Apart from this, other foremost functions of MMPs are organizing the spatial distribution of cells and portrayal of various protective and healing responses needed after injury, which include wound healing, tissue repair and remodelling damaged tissue. MMPs play a crucial role in both physiological and pathological angiogenic processes. They regulate various processes involved in cellular signalling pathways and primarily modulate cell growth, inflammatory response and the angiogenic events. [42, 43] During the advent of angiogenesis, degradation of subendothelial basement membrane and the adjacent components of extracellular matrix forms a crucial initiating event. It is succeeded by migration of endothelial cells to the stimulated site, where they proliferate and initiate the formation of new blood vessels. Studies have found that all the above-mentioned events are critically mediated by MMPs. Animal models of diabetic retinopathy have shown considerably increased expressions of MMP-2 and MMP-9. Although, physiologically, in critically regulated concentrations, MMPs are required for maintaining the integrity of BRB, their overactivation during hyperglycaemia-induced pathological conditions leads to increased proteolytic activity, resulting in breakdown of BRB. [44, 45] Hence, VEGF and MMPs greatly intensify inflammatory response and mediate retinal angiogenesis.
Besides, another inflammatory mediator induced during hyperglycaemia, COX-2, is said to upregulate angiogenesis. It leads to the production of various pro-inflammatory eicosanoids, such as prostaglandins and leukotrienes, whose downstream signalling further increases the expression of VEGF, thereby upregulating all VEGF-mediated angiogenic responses. Additionally, eicosanoids mediate induction of epidermal growth factor receptor-mediated angiogenesis, besides enhancing the survival of retinal endothelial cells via Akt (protein kinase B)-signalling pathway. [26] Henceforth, the above discussion concludes a critical role of VEGF, MMPs and COX-2 in inflammation-induced angiogenesis, leading to the progression of diabetic retinopathy.
Omega-3 fatty acids and retinal protection Alpha-linolenic acid
Diet containing high contents (50-60%) of ALAs includes seeds (e.g. flaxseed/linseed, pumpkin seeds), nuts (e.g. walnuts), green leafy vegetables, beans (e.g. soya bean) and oils (e.g. canola oil, olive oil, perilla seed oil). [46, 47] Various studies found that ALA possesses both cytoprotective as well as neuroprotective properties. It significantly decreases the levels of several inflammatory mediators, namely VEGF in animal models of streptozotocin-induced diabetic retinopathy, [48] besides inhibiting the production of pro-inflammatory cytokines such as interleukin-6 (IL-6), IL-1b and tumour necrosis factor (TNF-a).
The conjugated isomers of ALA manifest retardation of various oxidative stress-induced alterations such as increased activity of NOS, overexpression of inflammatory mediators, platelet aggregation, lipid peroxidation, protein oxidation and DNA damage. They also restitute the altered physiologies of various antioxidant enzymes, including superoxide dismutase, catalase, glutathione peroxidase, glutathione reductase and ferric reducing ability of plasma in rat model. [49] Hence, the above observations conclude that ALA (and its conjugated isomers) reduces free radical production as well as potentiating other antioxidant mechanisms of the body. Alpha-linolenic acid, in one study conducted in humans, also increases the levels of brain-derived neurotrophic factor, a neuroprotective protein, which protects neurons from various damaging stimuli, such as inflammation and oxidative stress, and enhances their survival, and therefore prevents retinal neuronal degeneration. [50] Hence, ALA reduces damage to endothelial and neuronal retinal cells by inhibiting oxidative stress-induced apoptosis, thereby preventing diabetic retinopathy.
Besides, oxygenated derivative of ALA, named 13-hydroxyoctadecadienoic acid, reduces IL-1b-induced expressions of various MMPs, such as MMP-1, MMP-3 and MMP-9, hence inhibiting inflammation as well as angiogenesis in diet-induced obese rats. [51] Thus, from the above discussion, it is concluded that ALA exhibits several protective actions against various diabetes-induced pathological alterations as validated from animal and human studies and therefore can be used to prevent the progression of diabetic retinopathy.
Eicosapentaenoic acid
Eicosapentaenoic acid is mainly obtained from fatty fish oil. EPA possesses anti-inflammatory properties due to its ability to affect the intracellular signalling pathways and, thereafter, the gene expression of various inflammatory mediators involved during an inflammatory response. This mainly occurs via EPA-induced inhibition of NF-jB, subsequently inhibiting the expressions of pro-inflammatory cytokines and adhesion molecules. Owing to inhibition of the same pathway, adhesion of monocytes/macrophages to endothelium is also significantly inhibited. [52, 53] The potential of EPA to inhibit the conversion of arachidonic acid into its pro-inflammatory metabolites (mainly prostaglandins and leukotrienes) is the most accepted molecular mechanism behind the portrayal of its antiinflammatory properties. It demonstrates the stated response by itself acting as a substrate for the enzymes involved in arachidonic acid metabolism, thereby preventing the production of a large number of pro-inflammatory products. In contrast to metabolic products of arachidonic acid, the products of EPA metabolism via the same pathway are much less inflammatory in nature. [54] Interestingly, a recent study concluded that EPA might also exhibit its anti-inflammatory actions via mediation through an Omega-3-epoxygenated metabolite, named 12-hydroxy-17, 18-epoxyeicosatetraenoic acid. This metabolite effectively reduces neutrophil infiltration; hence greatly downregulating chemotaxis. [55] Thus, inhibition of almost every step involved in an inflammatory response is efficaciously achieved by EPA, thereby preventing diabetic retinopathy. Besides, EPA greatly reduces inflammation-induced neovascularization. In animal models, EPA markedly reduces the transcription and translation of several inflammatory markers of neovascularization, namely ICAM-1, MCP-1, VEGF and IL-6. [56] Among these mediators, inhibition of the expression of VEGF is highly significant in preventing retinal angiogenesis. EPA greatly inhibits VEGF-induced endothelial cellular proliferation, migration and tube formation. This response is mediated via EPA-induced inhibition of foetal liver kinase-1 (Flk-1) receptor expression. [57] Flk-1 is a receptor for VEGFR2, which regulates mitogenesis and differentiation of vascular endothelial cells, and therefore angiogenesis, by activating phosphatidylinositol 3-kinase (PI3K) and subsequently mediating PI3K/S6 kinase pathway.
Another anti-angiogenic pathway is demonstrated by conjugated EPA, which inhibits cellular proliferation and tube formation in human umbilical vein endothelial cells via downregulating mRNA expression of MMP-2 and MMP-9, besides preventing their secretion during VEGFstimulated pathway. [58] Hence, EPA inhibits the various factors involved in retinal angiogenesis. Although some earlier studies reported devastating effects of EPA in inducing/ aggravating lipid peroxidation, a recent study has demonstrated completely opposite results.
According to the conclusions of a study conducted by Mahmoudabadi and Rahbar, administration of EPA increases several endogenous antioxidant enzymes, namely superoxide dismutase and glutathione peroxidase, while simultaneously decreasing the levels of malondialdehyde, a classical biomarker of oxidative stress, in type II diabetic patients. The various molecular effects produced by EPA result in an overall increase in the total antioxidant capacity of the diabetic patients. Hence, by facilitating increased scavenging of the free radicals, particularly superoxide radical and hydrogen peroxide, EPA exhibits protective effects on the endothelial and neuronal cells of retina. [59] This pathway is greatly beneficial in reducing all the microvascular complications, including diabetic retinopathy.
Thus, by inhibiting inflammation, angiogenesis and reducing oxidative stress, EPA acts as a defensive shield against the occurrence of diabetic retinopathy.
Docosahexaenoic acid
Like EPA, DHA is also mainly obtained from fish oil. Apart from similarity in their nutritional sources, studies show that EPA and DHA are also similar in most of their biological actions. DHA is also a strong anti-inflammatory agent due to its ability to inhibit many inflammatory mediators involved in the pathophysiology of diabetic retinopathy, namely cytokines and adhesion molecules. Docosahexaenoic acid markedly reduces the IL-1b-induced phosphorylation of I-jB (inhibitor of nuclear factor-jB), thereby preventing its degradation, which subsequently renders NF-jB in an inactive state. Thus, by inhibiting the activation of NF-jB and its subsequent translocation to the nucleus, DHA directly affects its downstream signalling and prevents the activation of its gene targets, which primarily includes cytokines (such as TNF-a). Further, as cytokines are responsible for activating cell adhesion molecules, such as ICAM-1 and VCAM-1, their downregulation diminishes the stimulation of various inflammatory mediators, thus preventing the retinal endothelial cells from a robust inflammatory response. [60] Apart from endothelial cells, an identical anti-inflammatory response of DHA is also observed in macrophages. However, it is highly dependent on the time and doseresponse elements associated with the stimulation of lipopolysaccharide in human monocyte-derived THP-1 macrophages. [61] Besides, DHA also inhibits the expression of VEGF via the same pathway, hence reducing its inflammatory as well as angiogenic stimulation. As it is known that reactive oxygen species, primarily superoxide radical, act as a second messenger in VEGF-mediated angiogenic signalling pathway, they play an integral part in retinal neovascularization as well. Studies concerning the molecular basis of the protective role of DHA in preventing VEGF-mediated angiogenesis have concluded the following -DHA greatly reduces the activity of NADPH (nicotinamide adenine dinucleotide phosphate) oxidase, an enzyme prominently responsible for the production of superoxide radical (required for VEGF signalling). Thus, DHA significantly decreases the production of superoxide radical, subsequently hampering VEGF-signalling pathway. [62] Docosahexaenoic acid also increases the bioavailability of NO (measured in form of the basal nitrite levels), independent of an elevation in the concentration of any isoform of NOS. Increased NO bioavailability due to diminished utilization of NO in the combination reaction with superoxide radical for the production of peroxynitrite -a highly reactive species involved in downstream angiogenic signalling of VEGF. [63] Moreover, increase in the levels of NO exhibits vasoprotective properties via anti-apoptotic and pro-survival actions, therefore further preventing the endothelial cells from oxidative damage. As eNOS is also necessary for VEGFmediated angiogenic signalling pathway, DHA-mediated inhibition of elevation in its concentration further decreases VEGF responsiveness, hence inhibiting angiogenesis. These responses of DHA were quantitatively much greater than those observed with EPA, thereby implying that the anti-inflammatory and antiangiogenic responses of DHA are more potent than EPA. [64] A study also reported DHA-induced upregulation of the activity of protein phosphatase 2A, an enzyme which regulates phosphorylation events. The induction of this enzyme by DHA reduces the phosphorylated form of ERK1/2 interrupting the activation of this signalling pathway induced by VEGF and eNOS, hence explaining the deleterious effects of DHA on eNOS activity. [65, 66] Thus, DHA maintains vascular integrity, besides inhibiting endothelial cell proliferation, migration, tube formation and subsequent retinal neovascularization.
Hence, owing to the mentioned protective effects of DHA, it can potentially be used in the prevention of diabetic retinopathy (Figure 2 ).
Conclusion
Omega-3 fatty acids have great potential to prevent the progression of diabetic retinopathy, due to their wide range of protective properties, such as anti-inflammatory, antiangiogenic, and antioxidant, among various others. They inhibit a wide range of inflammatory mediators involved in the pathophysiology of diabetic retinopathy, besides decreasing the formation of free radicals and inducing the expressions of endogenous antioxidant enzymes. Also, they remarkably prevent the initiation of retinal angiogenesis by downregulating the expressions of various angiogenic agents such as VEGF, MMPs and COX-2. Owing to the mentioned pharmacological activity, Omega-3 fatty acids greatly retard the advent of the characteristic pathological events characterizing diabetic retinopathy. Hence, these agents, besides being used for the treatment of other cardiovascular disorders, might also prove clinically beneficial in preventing the progression of this diabetic complication. Therefore, Omega-3 fatty acid-rich diet might greatly avert the risk of the development of diabetic retinopathy in diabetic patients.
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